Trial intelligence / Profile preview

NEUROIMPA - Intraarticular Application of Opioids in Chronic Arthritis of the Knee Joint

DRKS00011113Phase 3Recruiting

Sponsor
Charité – Universitätsmedizin Berlin
Start
Nov 2016
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3 trial of morphine and triamcinolone in knee arthritis and monoarthritis (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Started Nov 2016; status: recruiting.

02

Drugs

morphinetriamcinolone
03

Conditions

knee arthritismonoarthritis

Beyond the preview

Go deeper on DRKS00011113.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00011113.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call